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Abstract
Background There is evidence for the efficacy of psycho-
oncological interventions (POI) in randomized controlled
trials for cancer patients. Our objective was to explore,
under naturalistic conditions (using propensity score match-
ing), whether POI are effective to decrease anxiety, depression,
distress and overall psychopathological symptoms within
cancer patients and their partners.
Methods This study was conducted in the Oncology and
Hematology Center of a University clinic in Switzerland
with a group of 186 patients and 117 partners. Outcome
measures of mental health were the Hospital Anxiety and
Depression Scale and the Symptom Checklist (SCL-9-K).
Repeated-measures ANOVAs were used to analyze change
over time and group effects between individuals with POI
vs. without POI.
Results Highly distressed patients and their partners partic-
ipating in POI reported better mental health over time.
Among moderately distressed patients, a decrease over time
emerged in depression and distress independent of POI. No
effectiveness of POI could be demonstrated in moderately
distressed patients and partners.
Conclusion Most of the highly distressed patients receive
additional POI and therefore conclusions about the efficacy
of POI are difficult. For moderately distressed individuals,
POI as implemented in Switzerland does not improve men-
tal health in such patients and their partners, which may be
caused by very time limited POI treatments. Studies with
more intense POI treatments are needed.
Keywords Anxiety . Cancer . Depression . Effectiveness .
Psycho-oncological interventions . Propensity score
Introduction
Over the past two decades, numerous psycho-oncological
interventions (POI) have been developed to support patients
and partners in coping with cancer [1–6]. Psycho-
oncological interventions comprise a range of options, from
single consultations, psycho-education, and supportive
interventions to individualized psychotherapeutic treatments
for specific problem areas. Important target areas of POI are
anxiety, depression, and overall distress, as well as illness-
related quality of life. Meta-analyses on the efficacy of POI
have consistently shown moderate effects on anxiety (d=
0.42), depression (d=0.36), distress (d=0.31) and quality of
life (d=0.31) [7, 8]. Larger effect sizes were reported in
studies with a longer duration of POI (i.e., more than seven
sessions) [7].
To gain clear conclusions about the efficacy of psycho-
logical interventions, randomized controlled trials (RCT) are
regarded as the gold standard of outcome research [9]. The
general purpose of this research design is to ensure internal
validity, so that unbiased causal effects of specific treat-
ments can be deduced. However, some authors have raised
concerns about the external validity of RCT [10]. RCT
select participants according to eligibility criteria, which
raises concerns that participants differ from nonparticipants
[11, 12] and generalization of the findings would therefore
be limited. Moreover, RCTs create artificial treatment con-
ditions [13], because in clinical routine the therapy duration
is more flexible and treatment strategies are corrected in
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case of lack of improvement. In addition, patients make
decisions in favor of or against specific psychological inter-
ventions [14] depending on their own preferences and per-
sonal needs. For the evaluation of the effectiveness of POI a
pre–post design might give only insufficient evidence, self-
selected control conditions might be prone to biased results,
and RCTs have problems regarding generalizability. A
method through which to take these aspects into account
and increase internal validity without neglecting external
validity in non-randomized studies is the application of
propensity score matching [15], which guided us in this
study. A propensity score is a balancing score [16] between
two groups of patients, in our case patients with POI vs.
patients without POI. Baseline characteristics of patients are
used to generate the propensity score which reflects the
probability to receive POI given a specific baseline charac-
teristic. Propensity score matching takes these aspects into
account and increases internal validity without neglecting
external validity in non-randomized studies. In a different
approach, baseline characteristics can also be used in mul-
tivariable models, but the number of characteristics included
in the model is limited due to the low statistical power of
most studies. A disadvantage of all matching procedures is
the restriction of the dataset to patients with a successful
matching partner in the other treatment condition which
limits generalizability. However, internal validity increases
with propensity score matching and causal conclusions can
be drawn more appropriately.
The purpose of this study was to explore, under natural-
istic conditions, the effects of POI on anxiety, depression,
distress and general psychopathological symptoms. The
effects of POI were studied separately in highly and mod-
erately distressed cancer patients and their partners.
Methods
Design and procedure
Participating patients and their partners were recruited at an
interdisciplinary University hospital in Switzerland between
2004 and 2007 for a larger study examining the mental
health of patients with cancer, psycho-oncological treatments,
and long-term coping after being diagnosed with cancer [17].
The study was approved by the regional ethics committee and
participants gave informed consent before data acquisition.
For the present study, a cohort of patients and their partners
were recruited to explore the effects of POI. Patients and
partners were referred to the psycho-oncological service by
the hospital physicians. This referral was based on a clinical
decision by the responsible physician and was not done ran-
domly. The physician’s impression that the patient or the
partner might benefit from POI guided referral.
The first assessment took place within 4 weeks after
diagnosis (T1), the second after 6 months (T2), and the third
after 12 months (T3) after initial assessment. All cancer
patients (N=186) and their partners (N=117) with available
baseline data (T1) on anxiety, depression, distress, and gen-
eral psychopathology were included in the present study.
Patients without sufficient knowledge of the German
language or with a lack of physical capacity to com-
plete the questionnaire were excluded. Furthermore, patients
who died during the follow-up period of 12 months (n=25)
and their respective partners were not considered in this
analysis.
Participants
The response rate for patients during follow-up was 77.4 %
(n=144) after 6 months and 69.4 % (n=129) after
12 months. Of the 117 partners, 72 % (n=85) returned
completed questionnaires for the second assessment and
60.6 % (n=71) for the third assessment. Non-responding
patients were more often male (χ2=3.79, p=0.05). Corre-
spondingly, non-responding partners were more often fe-
male (χ 2=11.86, p=0.001). In both groups, responders
had a higher education level than non-responders (patients:
Mann–Whitney U test U=2,947, p=0.05; partners: Mann–
Whitney U test U=1,888, p=0.02).
Psycho-oncological treatment
Patients were treated in a Center for Oncology and Hema-
tology which is part of a University clinic in Switzerland.
Oncological care, as well as POI, was delivered primarily to
outpatients. In some cases, however, hospitalization (for
medical reasons) was necessary. In such cases, POI consul-
tations were delivered in the patient’s room.
Patients and their partners were referred to POI according
to their oncologist/hematologist’s clinical evaluation and
recommendation. The psycho-oncology unit consisted of
four experienced psycho-oncologists (two male, two
female) with heterogeneous psychotherapy training (i.e.,
psychodynamic, humanistic, systemic, body-oriented). Ses-
sion format (individual/couple/family) was decided mutual-
ly between patient and psycho-oncologist in accordance
with patients’ and partners’ needs. The POI was delivered
in a non-standardized way (i.e., neither length nor content
was pre-specified); however, common intervention strate-
gies were: psycho-education about psychological responses
to cancer; cognitive-restructuring, emotion-regulation and
behavior-control techniques (working with dysfunctional
cognitions, self-instruction, guided imagery, relaxation),
resource activation, training couple communication
skills, increased meaning-making, and death and grief
counseling.
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Outcome measures
Anxiety, depression, and distress
The German version of the Hospital Anxiety and Depres-
sion Scale (HADS) [17] was used to assess the extent of
anxiety, depression and overall distress. The 14-item HADS
was specifically developed for use with physically ill
patients. It consists of two subscales of seven items, each
of which is rated on a four-point Likert scale, resulting in a
score ranging from 0 to 21 on the anxiety and depression
subscales. Overall distress is determined by adding the
scores of the two subscales and thus ranged from 0 to 42.
Sound psychometric properties of the HADS have been
established [18, 19]; for our sample, the internal consisten-
cies were 0.84 (patients) and 0.85 (partners) for anxiety,
0.80 (patients) and 0.83 (partners) for depression, and 0.89
(patients) and 0.91 (partners) for distress.
General psychopathology
To assess general psychopathology, a validated German
short-form [20] of the Symptom Checklist SCL-90-R [21]
was applied. The SCL-9-K is a nine-item questionnaire that
assesses nine symptom dimensions (anxiety, depression,
hostility, interpersonal sensitivity, obsessive–compulsive-
ness, paranoid ideation, phobic anxiety, psychoticism,
somatization) and an overall psychopathology index, the
Global Severity Index (GSI). All items can be evaluated
on a five-point scale: (0) not at all, (1) a little bit, (2)
moderately, (3) quite a bit, (4) extremely. The GSI repre-
sents the mean score of all items (range from 0 to 4, with
higher scores indicating severe general psychopathology).
Internal consistencies of the GSI in our study were 0.85 for
patients and 0.88 for partners.
Medical and sociodemographic information
Oncologists provided diagnostic data, including cancer type
and stage [22], and classification of curative vs. palliative
care. Additionally, cancer localizations were classified in
major categories [23]. Sociodemographic information
includes age, gender, education, revenue, and relationship
status were based on participants’ self-reports.
Statistical analyses
Since POI were delivered based on clinical referral, match-
ing of patients with or without POI according to their
baseline characteristics was used to estimate treatment effi-
cacy independent of patient characteristics. In a first step,
propensity scores [16] were calculated; in a second step, a
nearest neighbor matching according to propensity scores
was used. Propensity scores ranged from 0 to 1 for each
patient and their respective partner and were determined by
multivariable logistic regression. A total of nine variables
were used as predictors: gender, age, cancer site, stage of
disease, cancer treatment approach (curative vs. palliative),
social support, mental health-related quality of life, anxiety
and depression. The use of POI was included as a dichoto-
mous outcome variable. Patients and partners with a pro-
pensity score over 0.70 can be labeled as highly distressed,
since mental distress and somatic health status was worse.
Equivalently, we labeled patients with a propensity score of
0.30 to 0.70 as moderately distressed (see Fig. 1) and
patients with a propensity score of 0.30 and below as suf-
fering from only low levels of distress.
We found that 86 and 79.2 % of highly distressed patients
and partners received POI. Therefore, treatment effects on
the four outcome measures were analyzed only for persons
having received POI. For moderately distressed patients (PS
0.30 to 0.70), we found that 50 % received POI. Differences
of baseline characteristics according to POI use were deter-
mined by Chi-square test, Mann–Whitney U test or t test
depending on the variables scale level.
For moderately distressed patients, an additional match-
ing procedure was used to create a subsample of patients
receiving POI and a subsample without this intervention.
For the one-to-one matching procedure, the nearest neighbor
caliper matching algorithm with a width of 0.05 was used to
find the closest control patient (without POI) for each pa-
tient with POI. A total of 35 patients were not matched at
this step. Effectiveness of the POI was studied by repeated
analyses of variance with the factors time and group
(POI or not).
For both highly and moderately distressed patients, the
effect size of changes between baseline and 1 year following
were calculated using Cohen’s d. The confidence intervals
of effect sizes were determined by the empirical correlation
between pre-scores and post-scores on the outcome measures
(intraclass correlations in our sample ranges between r=0.54
and r=0.85).
To account for missing information at follow-up, both
completer analyses and intent to treat analysis (ITT) were
conducted in sensitivity analyses. For the intent to treat
analysis we used two different procedures, namely the last
observation carried forward procedure and a multiple impu-
tation algorithm to fill in missing anxiety, depression, dis-
tress, and psychopathological values. Patients dropping out
during the follow-up period were more often males and had
lower education levels (p=0.05). Drop-outs and patients
with complete data did not differ on any other characteristic.
Analyses were performed with SPSS 18 for Windows, and
STATA psmatch2 was used for the propensity score-
matching procedure.
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Results
Sample description
For highly distressed patients and partners, the patients’
sample consisted of 56.8 % men and 43.2 % women. The
average age for highly distressed patients was 50 years (SD=
13.21). Established cutoff criteria of HADS-A and HADS-D
scores of 8 or over (moderate level) or a higher threshold of 11
or over (high level) were used to provide a clinical interpreta-
tion of anxiety and depression scores. About a quarter of
highly distressed patients were depressed (23.1 % moderate
level; 12.4 % high level) and anxious (21 % moderate level;
11.3 % high level) to a moderate extent. Highly distressed
partners were even more often depressed (56.2 % moderate
level; 25 % high level) and anxious (50 % moderate level;
18.7 % high level). Among highly distressed patients, 27 %
had hematological cancer, 21.9 % lung cancer, 18.9 % breast
cancer, and 16.2 % gastrointestinal cancer; 16.2 % had cancer
in other sites. Most of the highly distressed cancer patients
(56.8 %) and 62.5 % of their participating partners faced stage
IV cancer. Of all highly distressed patients, 54.1 % received
curative and 45.9 % palliative medical care. Among highly
distressed partners, curative or palliative treatment was deliv-
ered to the patients in a 50/50 split.
The moderately distressed subsample consisted of 66
patients (53 % male), 45 of whom had a partner (62.2 %
female). Moderately distressed patients and partners were on
average 56 years of age (SD=13.6) and 69.4 % had an
apprenticeship degree. Predominant cancer sites were gas-
trointestinal (28.8 %), hematological (27.3 %), lung
(16.7 %), and breast (15.2 %). Of moderately distressed
patients, 12 % had stage I (early) disease, 22.7 % stage II,
33.3 % stage III, and 31.8 % stage IV (advanced).
Concerning the medical treatment goal, 59.1 % of moderately
distressed patients received curative and 40.9 % palliative
care. Details of the moderately distressed sample are given
in Table 1.
The low distressed patients numbered 41 (53 % male), 26
of whom had a partner. These patients were on average
Total sample patients N = 186 (92 no POI vs. 94 POI)
Total sample partners N = 117 (60 no POI vs. 57 POI)
Grouping according to 
propensity scores
Propensity score < 0.3
(low distress)
Excluded from analysis
Patients N = 41
(32 no POI vs. 9 POI)
Partners N = 26
Propensity score 0.3 to 
0.7 (moderately 
distressed):
Patients N = 101
(53 no POI vs. 48 POI)
Partner N = 70
(35 no POI vs. 35 POI)
Propensity score > 0.7 
(highly distressed)
Patients N = 44 
(7 no POI vs. 37 POI)
Partners N = 21
(5 no POI vs. 16 POI)
Patients matched 
via propensity score
Number of matched patients 
N = 66
33 patients received POI
(completer analysis N = 24)
23 partners received POI
(completer analysis N = 15)
33 patients received no POI
(completer analysis N = 19)
22 partners received no POI
(completer analysis N = 12)
N = 35 excluded: no match
Fig. 1 Flowchart
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65.2 years of age (SD=11.5) and 87 % had an apprentice-
ship degree. Of these patients, 37 % had stage I (early)
disease, 53.7 % stage II, 2.4 % stage III, and 7.3 % stage
IV (advanced). The cancer sites most often present were
breast (39 %), prostate (24.4 %), and ovarian (20 %). The
medical treatment aimed at curative (87.8 %) and palliative
care (12.2 %).
Dose of psycho-oncological interventions
Of highly distressed patients, 86 % received POI, which
started on average 3 weeks after initial cancer diagnosis
(range=1 to 10 weeks). A total of 32 % of the highly dis-
tressed patients received one session, 37.8 % two to four
sessions and 29.7% five or more sessions.Mean POI intensity
for highly distressed patients was 6.62 sessions (SD=10.51;
range = 1 to 54 sessions). In all, 76 % of highly distressed
partners received POI, starting on average 7 weeks after their
partner’s initial cancer diagnosis (range = 1 to 28 weeks). Of
highly distressed partners, 12.5 % received one session,
37.5 % two to four sessions and 50 % five or more sessions.
Mean treatment intensity for highly distressed partners was
10.56 sessions (SD=13.73; range 1 to 54 sessions).
Among moderately distressed patients 50 % received
POI, which began about 11 weeks after initial cancer diag-
nosis (range=1 to 36 weeks). A total of 30.3 % of the
moderately distressed patients received one session,
36.4 % received two to four sessions and 30.3 % received
five or more sessions. The mean POI for moderately dis-
tressed patients was 4.66 sessions (SD=5.91; range=1 to 26
sessions). A total of 51 % of moderately distressed partners
received POI, which began around 13 weeks after their
partner’s initial cancer diagnosis (range=1 to 36 weeks).
Among moderately distressed partners 26.1 % received
one session, 30.4 % received two to four sessions and
39.1 % received five or more sessions. The mean treatment
intensity for moderately distressed partners was 4.86 ses-
sions (SD=5.10; range=1 to 17 sessions).
Table 1 Baseline characteristics
of moderately distressed patients
and partners according to
perceived psycho-oncological
intervention
CG control group; TG treatment
group
aTotal n patients = 33
bTotal n patients = 33
cTotal n partners = 22
dTotal n partners = 23
eChi-square test
fT test
gDue to missing data, percen-
tages do not add up to 100
hMann–Whitney U test
Patients Partners
Control Treatment p Control Treatment p
[na (%)] [nb (%)] [nc (%)] [nd (%)]
Gender 0.49e 0.78e
Female 18 (54.5) 13 (39.4) 11 (50.0) 17 (73.9)
Male 15 (45.5) 20 (60.6) 11 (50.0) 6 (26.1)
Age (years, SD) 57.8 (14.2) 56.5 (13.7) 0.72f 56.0 (14.4) 55.6 (12.3) 0.92f
Educationg 0.07h 0.59h
No graduation 2 (6.1) 4 (12.1) 2 (9.1) 5 (21.7)
Apprenticeship 21 (63.6)
University 8 (24.2) 3 (9.1) 0 (0.0) 0 (0)
Revenueg 0.74e 0.21e
Low < 40,000 Fr 8 (24.2) 8 (24.2) 4 (18.2) 5 (21.7)
High ≥ 40,000 Fr 23 (69.7) 24 (72.8) 18 (81.8) 18 (78.3)
Cancer site 0.66e 0.76e
Head and neck 2 (6.1) 3 (9.1) 1 (4.5) 2 (8.7)
Gastrointestinal 9 (27.3) 10 (30.3) 6 (27.3) 9 (39.1)
Breast 7 (21.2) 3 (9.1) 4 (18.2) 2 (8.7)
Lung 6 (18.2) 5 (15.2) 3 (13.6) 3 (13.0)
Genital (male) 0 (0.0) 1 (3.0) 0 (0.0) 1 (4.3)
Hematological 8 (24.2) 10 (30.3) 7 (31.8) 5 (21.7)
Other 1 (1.3) 2 (6.0) 1 (4.5) 1 (4.3)
Stage of cancer 0.78h 0.68h
Stage 1 4 (12.1) 4 (12.1) 2 (9.1) 2 (8.7)
Stage 2 7 (21.2) 8 (24.2) 4 (18.2) 5 (21.7)
Stage 3 11 (33.3) 11 (33.3) 10 (45.5) 7 (30.4)
Stage 4 11 (33.3) 10 (30.3) 6 (27.3) 9 (39.1)
Cancer treatment 0.47e 0.80e
Curative 19 (57.6) 20 (60.6) 13 (59.1) 14 (60.9)
Palliative 14 (42.4) 13 (39.4) 9 (40.9) 9 (39.1)
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Psycho-oncological treatment effects for highly distressed
patients and partners
Highly distressed patients showed a significant decrease in
psychological distress over time. Anxiety, depression, dis-
tress, and psychopathology (all p<0.05) were reduced after
the psycho-oncological treatment (see Table 2). The highest
treatment effect was detected for depression (d=0.52) and
the lowest for psychopathology (d=0.30). Within highly
distressed partners, a decrease in all outcomes was found,
although only anxiety (p=0.01) and distress (p=0.02)
reached the level of statistical significance. The largest
intervention effect was observed for anxiety (d=0.45) and
the lowest for psychopathology (d=0.22).
Equivalence of moderately distressed participants according
to use of psycho-oncological treatment
Before the matching procedure, moderately distressed
patients receiving POI were more anxious, depressed and
distressed, and showed more psychopathological symptoms
(all p<0.01) compared to patients without POI at baseline
(see Table 3). Partners receiving POI were also more anx-
ious (p=0.01) and distressed (p=0.02), and showed more
psychopathological symptoms (p=0.04) compared to part-
ners without POI at baseline (see Table 3). Comparable
score were found for depression. After propensity score
matching, patients’ mental health status on all measures
(anxiety, depression, distress, and psychopathology) was
equal regardless of POI use. The same situation was realized
for partners with equal scores on anxiety, depression, dis-
tress, and psychopathology measures.
Effectiveness of psycho-oncological interventions
on moderately distressed patients and partners
Results of completer analysis on the effect over time (pre–
post) and of the POI on mental health outcome measures are
shown in Table 4. Time effects within patients’ groups
showed significant decreases over time for depression (p=
0.03) and distress (p=0.05), but not for anxiety (p=0.13)
and psychopathology (p=0.30). It was hypothesized that the
interaction between time and group would be significant,
but completer analyses indicated no group effects on anxiety
(p=0.82), depression (p=0.83), distress (p=0.99), or psy-
chopathology (p=0.17). Additionally, in partners, no change
over time was found on any outcome measure (anxiety, p=
0.62; depression, p=0.93; distress, p=0.83; psychopatholo-
gy, p=0.76). Completer analyses showed no significant
effect of POI on anxiety (p=0.88), depression (p=0.53),
distress (p=0.68), or psychopathology (p=0.22).
ITT analyses on anxiety, depression, distress, and psy-
chopathology showed the same pattern of results for patients
and partners as the completer analyses (see Table 5). For
patients, results for depression and distress converged with
the completer analyses by demonstrating a significant re-
duction over time (p<0.05). There were no significant
effects of POI on anxiety (p=0.66), depression (p=0.79),
distress (p=0.90), and psychopathology (p=0.31). None of
the partners’ outcome measures changed over time (anxiety,
p=0.71; depression, p=0.75; distress, p=0.97; psychopa-
thology, p=0.86). Within partners there were no significant
differences between POI groups on anxiety (p=0.67), de-
pression (p=0.23), distress (p=0.40), and psychopathology
(p=0.18).
Discussion
Highly distressed cancer patients and their partners showed
a decrease in distress. Such a decrease in psychological
distress in the first year for initially highly distressed
patients and relatives may justify the implementation of
psycho-oncological services for clinical reasons since
patients use this service regularly which can be seen as a
need for such an intervention [24, 25]. Our data cannot
Table 2 Psycho-oncological
treatment effects for highly dis-
tressed patients and partners
(pre–post change)
M mean, SD standard deviation,
F F value, p p value, ES effect
size, CI confidence interval
an patients = 37
bn partners = 16
Baseline 12 months F p ES [95 % CI]
[M (SD)] [M (SD)]
Patientsa
Anxiety 8.48 (3.79) 7.18 (4.24) 6.26 0.01 0.32 0.05–0.58
Depression 7.45 (3.69) 5.38 (4.18) 13.58 0.001 0.52 0.21–0.83
Distress 15.94 (6.61) 12.56 (7.89) 12.04 0.001 0.46 0.18–0.74
Psychopathology 1.18 (0.68) 0.97 (0.71) 3.84 0.05 0.30 0.00–0.59
Partnersb
Anxiety 11.56 (4.70) 9.47 (4.45) 7.15 0.01 0.45 0.07–0.83
Depression 7.87 (3.86) 6.63 (3.94) 4.03 0.06 0.31 −0.01–0.65
Distress 19.43 (7.78) 16.09 (7.81) 6.20 0.02 0.42 0.05–0.80
Psychopathology 1.45 (1.06) 1.21 (1.10) 2.65 0.12 0.22 −0.05–0.50
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demonstrate whether POI were efficacious to improve men-
tal health in highly distressed cancer patients, since a control
group without POI was not available. A decrease in mental
distress over time was found in moderately distressed
patients. However, no decrease in psychological distress
was observed among partners.
No efficacy of the POI was found in moderately dis-
tressed patients and partners. This could be due to the low
mean scores on the HADS [17] and the SCL-9-K [20],
which indicates clinically meaningful distress for a part of
the patients only. Some authors have argued that efficacy of
psycho-oncological interventions cannot be expected in
moderately distressed patients [24], which is in line with
some conflicting results in reviews [26, 27]. As an alterna-
tive explanation, low intensity of POI may limit its effec-
tiveness. This view is supported by meta-analyses [7, 8]
Table 3 Equivalence of control
group (CG) and treatment group
(TG) before and after matching
procedure
aCG n patients = 92;
TG n patients = 94
bCG n patients = 33;
TG n patients = 33
c CG n partners = 60;
TG n partners = 57
d CG n partners = 22;
TG n partners = 23
CG TG p CG TG p
M (SD) M (SD) M (SD) M (SD)
Patients Before matchinga After matchingb
Anxiety 4.84 (3.53) 6.95 (4.12) 0.01 5.70 (3.41) 6.36 (3.75) 0.45
Depression 4.37 (3.56) 5.90 (3.90) 0.01 4.82 (3.31) 5.06 (3.42) 0.77
Distress 9.21 (6.39) 12.85 (7.53) 0.01 10.52 (5.78) 11.42 (6.79) 0.56
Psychopathology 0.64 (0.54) 0.94 (0.64) 0.01 0.77 (0.63) 0.82 (0.57) 0.74
Partners Before matchingc After matchingd
Anxiety 7.10 (4.09) 9.56 (4.46) 0.01 8.27 (4.18) 8.87 (3.67) 0.61
Depression 5.78 (4.42) 6.68 (3.99) 0.25 6.45 (4.58) 6.09 (3.83) 0.77
Distress 12.88 (8.16) 16.24(7.94) 0.02 14.73 (8.46) 14.96 (7.27) 0.92
Psychopathology 0.84 (0.62) 1.12 (0.87) 0.04 1.05 (0.70) 1.06 (0.87) 0.97
Table 4 Psycho-oncological intervention effects of psycho-oncological intervention (TG) compared to persons without treatment (CG) in
moderately distressed patients and partners: completer analyses
Group Baseline 12 months ANOVAa ES [95 % CI]
[M (SD)] [M (SD)] Time Time×group
F p F p
Patientsb
Anxiety CG 6.58 (3.48) 5.00 (3.00) 2.38 0.13 0.02 0.82 −0.04 −0.64–0.55
TG 5.96 (3.83) 4.83 (4.27) 0.27 −0.15–0.71
Depression CG 4.11 (2.94) 3.63 (3.04) 4.75 0.03 0.04 0.83 0.31 −0.29–0.91
TG 4.83 (3.55) 4.67 (3.63) 0.04 −0.40–0.49
Distress CG 10.68 (6.07) 8.63 (5.71) 3.97 0.05 0.00 0.99 0.13 −0.47–0.73
TG 10.79 (6.94) 9.50 (7.47) 0.17 −0.25–0.61
Psychopath CG 0.94 (0.76) 0.67 (0.50) 1.08 0.30 1.91 0.17 0.16 −0.44–0.76
TG 0.73 (0.49) 0.76 (0.61) −0.05 −0.48–0.38
Partnersc
Anxiety CG 7.17 (3.12) 4.75 (3.16) 0.24 0.62 0.02 0.88 0.77 0.13–1.40
TG 8.67 (3.75) 6.97 (3.74) 0.45 −0.05–0.96
Depression CG 4.83 (3.32) 3.25 (2.52) 0.08 0.93 0.40 0.53 0.53 −0.05–1.12
TG 5.53 (3.44) 4.93 (3.61) 0.17 −0.32–0.66
Distress CG 12.00 (6.03) 8.00 (5.42) 0.04 0.83 0.16 0.68 0.69 0.08–1.31
TG 14.20 (7.00) 11.91(7.14) 0.32 −0.17–0.82
Psychopath. CG 0.80 (0.55) 0.39 (0.30) 0.09 0.76 1.52 0.22 0.92 0.19–1.65
TG 0.83 (0.53) 0.72 (0.50) 0.21 −0.34–0.76
a Covariate: gender
b CG n patients = 19; TG n patients = 24
c CG n partners = 12; TG n partners = 15
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which showed that therapy duration is an important predictor
of POI efficacy.
A major strength of our study was that threats to internal
validity were reduced by propensity score matching [15].
Despite a gain in internal validity, confounders were not
controlled in this type of study design. Randomization is
still the gold standard in efficacy research, but random
allocation is not always feasible or ethical [28]. Propensity
score matching allowed coming to more meaningful results
with data from naturalistic setting than regular analysis by
incorporating baseline differences between individuals.
However, some limitations of this study should be noted.
Propensity score matching has the disadvantage that large
initial samples are needed and, due to missing matches, this
initial sample will be reduced dramatically. In our study, we
faced the problem that the number of patients in the highly
distressed group without POI was low, and an analysis of the
efficacy of POI in this group was not possible. The sample
size was rather small, and it was not possible to analyze
established predictors in psycho-oncological effectiveness
studies (e.g., gender, age). The heterogeneity of the
interventions did increase external validity and reflects clin-
ical practice in psycho-oncology [29], but has limits if
specific intervention strategies are of interest. The initial
assessment of mental distress was carried out in the 4-
week period after cancer diagnosis, which might have intro-
duced bias due to the different coping stages of patients and
partners. Another bias might be introduced by a higher rate
of males and patients with lower education in the drop-outs.
In conclusion, our study showed an improvement of
mental health in highly distressed cancer patients and their
relatives over time. Since a control group without POI is
missing, conclusions about the efficacy of POI in highly
distressed subjects cannot be drawn. But the positive change
of mental distress shows effects of a comprehensive reha-
bilitation program. Our results did not provide evidence for
the effectiveness of POI in moderately distressed patients
and partners, which might be partly explained by two estab-
lished predictors of low treatment effects, namely low dis-
tress and low treatment dose. Our findings indicate that
further research should clarify whether POI meet the needs
of moderately distressed patients and partners, and if higher
Table 5 Psycho-oncological intervention effects of psycho-oncological intervention (TG) compared to persons without treatment (CG) in
moderately distressed patients and partners: intent to treat analyses (LOCF)
Group Baseline 12 months ANOVAa ES 95% CI
M (SD) M (SD) Time Time×group
F p F p
Patientsb
Anxiety CG 5.70 (3.41) 5.09 (2.93) 3.67 0.06 0.19 0.66 0.19 −0.13–0.52
TG 6.36 (3.75) 5.58 (4.41) 0.19 −0.14–0.51
Depression CG 4.82 (3.31) 4.33 (3.20) 3.94 0.05 0.06 0.79 0.15 −0.17–0.46
TG 5.06 (3.42) 5.00 (3.58) 0.01 −0.30–0.34
Distress CG 10.52 (5.78) 9.42 (5.51) 4.56 0.03 0.01 0.90 0.19 −0.19–0.52
TG 11.42 (6.79) 10.58 (7.63) 0.11 −0.20–0.44
Psychopath CG 0.77 (0.63) 0.64 (0.47) 0.82 0.36 1.04 0.31 0.23 −0.08–0.55
TG 0.82 (0.57) 0.84 (0.67) −0.03 −0.34–0.28
Partnersc
Anxiety CG 8.27 (4.18) 6.55 (4.12) 0.13 0.71 0.17 0.67 0.41 0.04–0.78
TG 8.87 (3.67) 7.90 (4.11) 0.24 −0.09–0.59
Depression CG 6.45 (4.58) 5.00 (4.03) 0.09 0.75 1.42 0.23 0.33 −0.00–0.68
TG 6.09 (3.83) 5.87 (4.01) 0.05 −0.26–0.37
Distress CG 14.73 (8.46) 11.55 (7.93) 0.00 0.97 0.71 0.40 0.38 0.03–0.73
TG 14.96 (7.27) 13.77 (7.90) 0.15 −0.16–0.48
Psychopath CG 1.05 (0.70) 0.71 (0.61) 0.03 0.86 1.85 0.18 0.51 0.18–0.85
TG 1.06 (0.87) 0.97 (0.81) 0.10 −0.18–0.39
LOCF last observation carried forward
a Covariate: gender
b CG n patients = 33; TG n patients = 33
c CG n partners = 22; TG n partners = 23
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treatment intensity would be required to achieve more ben-
eficial outcomes.
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